An investigation was performed and no kit issues were identified relating to (b)(6) results.Based on the results generated for this donor, it is suspected that the donor was infected between (b)(6) 2018 and (b)(6) 2019, with a low level (b)(6) infection, which may not consistently be detected by the cobas mpx test, where serology was (b)(6) due to the lack of seroconversion (window period).The cobas mpx test, ce ivd instructions for use indicates "detection of hiv-1 group m rna, hiv-1 group o rna, hiv-2 rna, hcv rna, and hbv dna is dependent on the number of virus particles present in the sample and may be affected by sample collection, storage and handling, patient factors (i.E., age, presence of symptoms), and/or stage of infection and pool size." the material number for the cobas mpx test, 96t, us-ivd is 06998909190.(b)(4).
|
A (b)(6) customer alleged the generation of a (b)(6) sample tested with the cobas mpx test for use on the cobas 6800/8800 system ((b)(6) 2019) in pool of 8.As the result in (b)(6) 2019 matched (b)(6) serology results, the donation was released and there are two recipients of this donation.It is confirmed that one patient received the thrombocyte concentrate and is being monitored.There is no information regarding if the second patient received the erythrocyte concentrate.In (b)(6) 2019, the customer received an anonymous call requesting that the donor be drawn and tested again.A new donation and previous donations from (b)(6) 2019 and (b)(6) 2018 were tested in (b)(6) 2019.The new donation and the donation from (b)(6) 2019 generated (b)(6) results and the donation from (b)(6) 2018 generated (b)(6) results.The serology for this donor was (b)(6).
|
(b)(6) 2019, it was indicated that the second recipient received the erythrocyte concentration; this information was unknown at the time of filing the initial mdr report.Additionally, it was noted that both recipients have a viral load of 6.8-7*10^6 iu/ml, but it is unclear what test method was used to test the recipients.
|